Tadashi Yoshida

Prof. Dr. Tadashi Yoshida

Apheresis and Dialysis Center, Keio University School of Medicine, Tokyo, Japan

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 July 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
Tadashi YoshidaTadashi Yoshida
Tadashi Yoshida
MYMaho Yamashita
Maho Yamashita
MHMatsuhiko Hayashi
Matsuhiko Hayashi
Hyperphosphatemia in chronic kidney disease is highly associated with vascular calcification. Previous studies have shown that high phosphate-induced phenotypic switching of vascular smooth muscle cells (SMCs) into osteogenic cells plays an important role in the calcification process. In the present study, we determined whether Krüppel-like factor 4 (Klf4) and phosphorylated Elk-1, transcriptional repressors of SMC differentiation marker genes activated by intimal atherogenic stimuli, contributed to this process. Rat aortic SMCs were cultured in the medium with normal (0.9 mmol/liter) or high (4.5 mmol/liter) phosphate concentration. Results showed that high phosphate concentration induced SMC calcification. Moreover, high phosphate decreased expression of SMC differentiation marker genes including smooth muscle α-actin and SM22α, whereas it increased expression of osteogenic genes, such as Runx2 and osteopontin. High phosphate also induced Klf4 expression, although it did not phosphorylate Elk-1. In response to high phosphate, Klf4 selectively bound to the promoter regions of SMC differentiation marker genes. Of importance, siRNA-mediated knockdown of Klf4 blunted high phosphate-induced suppression of SMC differentiation marker genes, as well as increases in expression of osteogenic genes and calcium deposition. Klf4 was also induced markedly in the calcified aorta of adenine-induced uremic rats. Results provide novel evidence that Klf4 mediates high phosphate-induced conversion of SMCs into osteogenic cells.

20 May 2013 in Journal of the American Heart Association
Verified
Journal Article
Open access
Tadashi YoshidaTadashi Yoshida
Tadashi Yoshida
MYMaho Yamashita
Maho Yamashita
CHChihiro Horimai
Chihiro Horimai
MHMatsuhiko Hayashi
Matsuhiko Hayashi
Background: Vascular proliferative diseases such as atherosclerosis are inflammatory disorders involving multiple cell types including macrophages, lymphocytes, endothelial cells, and smooth muscle cells ( SMC s). Although activation of the nuclear factor‐κB ( NF ‐κB) pathway in vessels has been shown to be critical for the progression of vascular diseases, the cell‐autonomous role of NF ‐κB within SMC s has not been fully understood. Methods and Results: We generated SMC ‐selective truncated IκB expressing ( SM 22α‐Cre/IκBΔN) mice, in which NF ‐κB was inhibited selectively in SMC s, and analyzed their phenotype following carotid injury. Results showed that neointima formation was markedly reduced in SM 22α‐Cre/IκBΔN mice after injury. Although vascular injury induced downregulation of expression of SMC differentiation markers and myocardin , a potent activator of SMC differentiation markers, repression of these markers and myocardin was attenuated in SM 22α‐Cre/IκBΔN mice. Consistent with these findings, NF ‐κB activation by interleukin‐1β ( IL ‐1β) decreased expression of SMC differentiation markers as well as myocardin in cultured SMC s. Inhibition of NF ‐κB signaling by BAY 11‐7082 attenuated repressive effects of IL ‐1β. Of interest, Krüppel‐like factor 4 (Klf4), a transcription factor critical for regulating SMC differentiation and proliferation, was also involved in IL ‐1β‐mediated myocardin repression. Promoter analyses and chromatin immunoprecipitation assays revealed that NF ‐κB repressed myocardin by binding to the myocardin promoter region in concert with Klf4. Conclusions: These results provide novel evidence that activation of the NF ‐κB pathway cell‐autonomously mediates SMC phenotypic switching and contributes to neointima formation following vascular injury.

1 September 2014 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PDF file
Tadashi YoshidaTadashi Yoshida
Tadashi Yoshida
MYMaho Yamashita
Maho Yamashita
CHChihiro Horimai
Chihiro Horimai
MHMatsuhiko Hayashi
Matsuhiko Hayashi
Kruppel-like factor 4 (KLF4) plays an important role in vascular diseases, including atherosclerosis and vascular injury. Although KLF4 is expressed in the heart in addition to vascular cells, the role of KLF4 in cardiac disease has not been fully determined. The goals of this study were to investigate the role of KLF4 in cardiac hypertrophy and to determine the underlying mechanisms. Cardiomyocyte-specific Klf4 knockout (CM Klf4 KO) mice were generated by the Cre/LoxP technique. Cardiac hypertrophy was induced by chronic infusion of the β-adrenoreceptor agonist isoproterenol (ISO). Results showed that ISO-induced cardiac hypertrophy was enhanced in CM Klf4 KO mice compared with control mice. Accelerated cardiac hypertrophy in CM Klf4 KO mice was accompanied by the augmented cellular enlargement of cardiomyocytes as well as the exaggerated expression of fetal cardiac genes, including atrial natriuretic factor (Nppa). Additionally, induction of myocardin, a transcriptional cofactor regulating fetal cardiac genes, was enhanced in CM Klf4 KO mice. Interestingly, KLF4 regulated Nppa expression by modulating the expression and activity of myocardin, providing a mechanical basis for accelerated cardiac hypertrophy in CM Klf4 KO mice. Moreover, we showed that KLF4 mediated the antihypertrophic effect of trichostatin A, a histone deacetylase inhibitor, because ISO-induced cardiac hypertrophy in CM Klf4 KO mice was attenuated by olmesartan, an angiotensin II type 1 antagonist, but not by trichostatin A. These results provide novel evidence that KLF4 is a regulator of cardiac hypertrophy by modulating the expression and the activity of myocardin.

15 October 2015 in Journal of the American Society of Nephrology
Verified
Journal Article
Open access
PDF file
Tadashi YoshidaTadashi Yoshida
Tadashi Yoshida
MYMaho Yamashita
Maho Yamashita
MIMieko Iwai
Mieko Iwai
MHMatsuhiko Hayashi
Matsuhiko Hayashi
Endothelial cells participate in the pathophysiology of ischemic AKI by increasing the expression of cell adhesion molecules and by recruiting inflammatory cells. We previously showed that endothelial Krüppel-like factor 4 (Klf4) regulates vascular cell adhesion molecule 1 (Vcam1) expression and neointimal formation after carotid injury. In this study, we determined whether endothelial Klf4 is involved in ischemic AKI using endothelial Klf4 conditional knockout (Klf4 cKO) mice generated by breeding Tek-Cre mice and Klf4 floxed mice. Klf4 cKO mice were phenotypically normal before surgery. However, after renal ischemia-reperfusion injury, Klf4 cKO mice exhibited elevated serum levels of urea nitrogen and creatinine and aggravated renal histology compared with those of Klf4 floxed controls. Moreover, Klf4 cKO mice exhibited enhanced accumulation of neutrophils and lymphocytes and elevated expression of cell adhesion molecules, including Vcam1 and Icam1, in injured kidneys. Notably, statins ameliorated renal ischemia-reperfusion injury in control mice but not in Klf4 cKO mice. Mechanistic analyses in cultured endothelial cells revealed that statins increased KLF4 expression and that KLF4 mediated the suppressive effect of statins on TNF-α–induced VCAM1 expression by reducing NF-κB binding to the VCAM1 promoter. These results provide evidence that endothelial Klf4 is renoprotective and mediates statin-induced protection against ischemic AKI by regulating the expression of cell adhesion molecules and concomitant recruitment of inflammatory cells.

1 November 2017 in Journal of the American Heart Association
Verified
Journal Article
Open access
PDF file
Tadashi YoshidaTadashi Yoshida
Tadashi Yoshida
MYMaho Yamashita
Maho Yamashita
CHChihiro Horimai
Chihiro Horimai
MHMatsuhiko Hayashi
Matsuhiko Hayashi
Background: Hyperphosphatemia is a major factor promoting the formation of arterial medial calcification in chronic kidney disease ( CKD ). However, arterial medial calcification begins to occur during the early stages of CKD , when hyperphosphatemia is not yet apparent. It is predicted that other factors also play a role. The aim of the present study was to determine the role of pro‐inflammatory nuclear factor‐κB ( NF ‐κB) signaling in smooth muscle cells ( SMC s) for phosphate‐induced arterial medial calcification in CKD mice. Methods and Results: We first sought to establish a novel mouse model of CKD with arterial medial calcification. CKD was induced in DBA /2 mice by feeding them a low concentration of adenine, and these mice were fed a normal or high‐phosphorus diet. Severe calcification was seen in CKD mice fed the high‐phosphorus diet, while it was undetectable in CKD mice fed the normal phosphorus diet or control mice fed the high‐phosphorus diet. Arterial medial calcification was accompanied by phenotypic switching of SMC s into osteogenic cells. Interestingly, NF ‐κB inhibitors, tempol and triptolide, both reduced arterial medial calcification in CKD mice fed the high‐phosphorus diet. Moreover, formation of arterial medial calcification, as well as SMC phenotypic switching, was also markedly attenuated in transgenic mice, in which the NF ‐κB activity was inhibited selectively in SMC s. Mechanistic studies revealed that Krüppel‐like factor 4 was involved in NF ‐κB‐induced SMC phenotypic switching and calcification. Conclusions: Results of the present studies suggest that the NF ‐κB signaling in SMC s plays an important role in high phosphate‐induced arterial medial calcification in CKD .

27 January 2014 in Journal of the American Heart Association
Verified
Journal Article
Open access
Tadashi YoshidaTadashi Yoshida
Tadashi Yoshida
MYMaho Yamashita
Maho Yamashita
CHChihiro Horimai
Chihiro Horimai
MHMatsuhiko Hayashi
Matsuhiko Hayashi
Background: Krüppel‐like factor 4 (Klf4) is involved in a variety of cellular functions by activating or repressing the transcription of multiple genes. Results of previous studies showed that tamoxifen‐inducible global deletion of the Klf4 gene in mice accelerated neointimal formation following vascular injury, in part via enhanced proliferation of smooth muscle cells ( SMC s). Because Klf4 is also expressed in non‐ SMC s including endothelial cells ( EC s), we determined if Tie2 promoter‐dependent deletion of Klf4 in EC s and hematopoietic cells affected injury‐induced neointimal formation. Methods and Results: Klf4 conditional knockout ( cKO ) mice were generated by breeding Tie2‐Cre mice and Klf4 floxed mice, and their phenotype was analyzed after carotid ligation injury. Results showed that injury‐induced repression of SMC differentiation markers was unaffected by Tie2 promoter‐dependent Klf4 deletion. However, of interest, neointimal formation was significantly enhanced in Klf4 ‐ cKO mice 21 days following carotid injury. Moreover, Klf4 ‐ cKO mice exhibited an augmented proliferation rate, enhanced accumulation of macrophages and T lymphocytes, and elevated expression of cell adhesion molecules including vascular cell adhesion molecule–1 (Vcam1) and E‐selectin in injured arteries. Mechanistic analyses in cultured ECs revealed that Klf4 inhibited tumor necrosis factor‐α–induced expression of Vcam1 through blocking the binding of nuclear factor‐κB to the Vcam1 promoter. Conclusions: These results provide evidence that Klf4 in non‐ SMC s such as EC s regulates neointimal formation by repressing arterial inflammation following vascular injury.